A DRUG said to halt the onset of Alzheimer’s disease could be on the market in several years' time after a promising performance in clinical trials.
Scientists from Aberdeen University have found the treatment, known as LMTX, could offer sufferers of the degenerative neurological disorder an extra 15 years of lucidity.